Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Drug Eluting Stents (DES) Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Drug Eluting Stents (DES) Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Cobalt-chromium alloy Stents
      • 1.3.3 Magnesium alloy Stents
      • 1.3.4 Tyrosine polycarbonate Stents
      • 1.3.5 Nitinol Stents
      • 1.3.6 Platinum chromium alloy Stents
      • 1.3.7 Stainless steel Stents
      • 1.3.8 Other Materials
    • 1.4 Market Segment by Application
      • 1.4.1 Global Drug Eluting Stents (DES) Market Share by Application (2019-2025)
      • 1.4.2 Coronary Heart Disease
      • 1.4.3 Clinical
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Drug Eluting Stents (DES) Production Value 2014-2025
      • 2.1.2 Global Drug Eluting Stents (DES) Production 2014-2025
      • 2.1.3 Global Drug Eluting Stents (DES) Capacity 2014-2025
      • 2.1.4 Global Drug Eluting Stents (DES) Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Drug Eluting Stents (DES) Market Size CAGR of Key Regions
      • 2.2.2 Global Drug Eluting Stents (DES) Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Drug Eluting Stents (DES) Capacity by Manufacturers
      • 3.1.2 Global Drug Eluting Stents (DES) Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Drug Eluting Stents (DES) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Drug Eluting Stents (DES) Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Drug Eluting Stents (DES) Market Concentration Ratio (CR5 and HHI)
    • 3.3 Drug Eluting Stents (DES) Price by Manufacturers
    • 3.4 Key Manufacturers Drug Eluting Stents (DES) Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Drug Eluting Stents (DES) Market
    • 3.6 Key Manufacturers Drug Eluting Stents (DES) Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Cobalt-chromium alloy Stents Production and Production Value (2014-2019)
      • 4.1.2 Magnesium alloy Stents Production and Production Value (2014-2019)
      • 4.1.3 Tyrosine polycarbonate Stents Production and Production Value (2014-2019)
      • 4.1.4 Nitinol Stents Production and Production Value (2014-2019)
      • 4.1.5 Platinum chromium alloy Stents Production and Production Value (2014-2019)
      • 4.1.6 Stainless steel Stents Production and Production Value (2014-2019)
      • 4.1.7 Other Materials Production and Production Value (2014-2019)
    • 4.2 Global Drug Eluting Stents (DES) Production Market Share by Type
    • 4.3 Global Drug Eluting Stents (DES) Production Value Market Share by Type
    • 4.4 Drug Eluting Stents (DES) Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Drug Eluting Stents (DES) Consumption by Application

    6 Production by Regions

    • 6.1 Global Drug Eluting Stents (DES) Production (History Data) by Regions 2014-2019
    • 6.2 Global Drug Eluting Stents (DES) Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Drug Eluting Stents (DES) Production Growth Rate 2014-2019
      • 6.3.2 United States Drug Eluting Stents (DES) Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Drug Eluting Stents (DES) Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Drug Eluting Stents (DES) Production Growth Rate 2014-2019
      • 6.4.2 European Union Drug Eluting Stents (DES) Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Drug Eluting Stents (DES) Import & Export
    • 6.5 China
      • 6.5.1 China Drug Eluting Stents (DES) Production Growth Rate 2014-2019
      • 6.5.2 China Drug Eluting Stents (DES) Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Drug Eluting Stents (DES) Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Drug Eluting Stents (DES) Consumption by Regions

    • 7.1 Global Drug Eluting Stents (DES) Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Drug Eluting Stents (DES) Consumption by Type
      • 7.2.2 United States Drug Eluting Stents (DES) Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Drug Eluting Stents (DES) Consumption by Type
      • 7.3.2 European Union Drug Eluting Stents (DES) Consumption by Application
    • 7.4 China
      • 7.4.1 China Drug Eluting Stents (DES) Consumption by Type
      • 7.4.2 China Drug Eluting Stents (DES) Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Drug Eluting Stents (DES) Consumption by Type
      • 7.5.2 Rest of World Drug Eluting Stents (DES) Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Abbott Vascular
      • 8.1.1 Abbott Vascular Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Drug Eluting Stents (DES)
      • 8.1.4 Drug Eluting Stents (DES) Product Introduction
      • 8.1.5 Abbott Vascular Recent Development
    • 8.2 Advantec Vascular
      • 8.2.1 Advantec Vascular Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Drug Eluting Stents (DES)
      • 8.2.4 Drug Eluting Stents (DES) Product Introduction
      • 8.2.5 Advantec Vascular Recent Development
    • 8.3 B.Braun Melsengen AG
      • 8.3.1 B.Braun Melsengen AG Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Drug Eluting Stents (DES)
      • 8.3.4 Drug Eluting Stents (DES) Product Introduction
      • 8.3.5 B.Braun Melsengen AG Recent Development
    • 8.4 Biosensors
      • 8.4.1 Biosensors Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Drug Eluting Stents (DES)
      • 8.4.4 Drug Eluting Stents (DES) Product Introduction
      • 8.4.5 Biosensors Recent Development
    • 8.5 Biotronik
      • 8.5.1 Biotronik Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Drug Eluting Stents (DES)
      • 8.5.4 Drug Eluting Stents (DES) Product Introduction
      • 8.5.5 Biotronik Recent Development
    • 8.6 Blue Medical
      • 8.6.1 Blue Medical Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Drug Eluting Stents (DES)
      • 8.6.4 Drug Eluting Stents (DES) Product Introduction
      • 8.6.5 Blue Medical Recent Development
    • 8.7 Boston Scientific
      • 8.7.1 Boston Scientific Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Drug Eluting Stents (DES)
      • 8.7.4 Drug Eluting Stents (DES) Product Introduction
      • 8.7.5 Boston Scientific Recent Development
    • 8.8 DISA Vascular
      • 8.8.1 DISA Vascular Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Drug Eluting Stents (DES)
      • 8.8.4 Drug Eluting Stents (DES) Product Introduction
      • 8.8.5 DISA Vascular Recent Development
    • 8.9 Essen
      • 8.9.1 Essen Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Drug Eluting Stents (DES)
      • 8.9.4 Drug Eluting Stents (DES) Product Introduction
      • 8.9.5 Essen Recent Development
    • 8.10 Medtronic Vascular
      • 8.10.1 Medtronic Vascular Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Drug Eluting Stents (DES)
      • 8.10.4 Drug Eluting Stents (DES) Product Introduction
      • 8.10.5 Medtronic Vascular Recent Development
    • 8.11 MicroPort Medical
    • 8.12 MIV Therapeutics
    • 8.13 Orbusneich
    • 8.14 Promed Medical
    • 8.15 Relisys Medical
    • 8.16 Reva Medical
    • 8.17 Sahajanand
    • 8.18 Sino Medical
    • 8.19 Sorin
    • 8.20 Terumo Medical

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Drug Eluting Stents (DES) Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Drug Eluting Stents (DES) Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Drug Eluting Stents (DES) Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Drug Eluting Stents (DES) Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Drug Eluting Stents (DES) Production Forecast by Type
      • 9.7.2 Global Drug Eluting Stents (DES) Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Drug Eluting Stents (DES) Sales Channels
      • 10.2.2 Drug Eluting Stents (DES) Distributors
    • 10.3 Drug Eluting Stents (DES) Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      In 2019, the market size of Drug Eluting Stents (DES) is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drug Eluting Stents (DES).

      This report studies the global market size of Drug Eluting Stents (DES), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Drug Eluting Stents (DES) production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Abbott Vascular
      Advantec Vascular
      B.Braun Melsengen AG
      Biosensors
      Biotronik
      Blue Medical
      Boston Scientific
      DISA Vascular
      Essen
      Medtronic Vascular
      MicroPort Medical
      MIV Therapeutics
      Orbusneich
      Promed Medical
      Relisys Medical
      Reva Medical
      Sahajanand
      Sino Medical
      Sorin
      Terumo Medical

      Market Segment by Product Type
      Cobalt-chromium alloy Stents
      Magnesium alloy Stents
      Tyrosine polycarbonate Stents
      Nitinol Stents
      Platinum chromium alloy Stents
      Stainless steel Stents
      Other Materials

      Market Segment by Application
      Coronary Heart Disease
      Clinical

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Drug Eluting Stents (DES) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Drug Eluting Stents (DES) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Drug Eluting Stents (DES) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now